Tyloxapol inhibits NF-kappa B and cytokine release, scavenges HOCI, and reduces viscosity of cystic fibrosis sputum.
Ghio, A J, Marshall, B C, Diaz, J L, Hasegawa, T, Samuelson, W, Povia, D, Kennedy, T P, Piantodosi, C AVolume:
154
Language:
english
Journal:
American Journal of Respiratory and Critical Care Medicine
DOI:
10.1164/ajrccm.154.3.8810619
Date:
September, 1996
File:
PDF, 667 KB
english, 1996